A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. Petitioners say that will appeal the ruling.
Today, Judge Alvin K. Hellerstein of the U.S. District Court for the Southern District of New York heard oral arguments on the motion to dismiss Washington, et.al v. Sessions, et.al, a federal lawsuit challenging the constitutionality of the Schedule I classification of cannabis under the Controlled Substances Act. The federal government argued to have the case dismissed. Judge Alvin K. Hellerstein of the U.S. District Court Southern District of New York reserved the decision.
The high court found that the prosecutor did not have the legal authority to hire his own people to drive up and down the highways, making traffic stops and searching vehicles for drugs.
Representatives of Florida for Care filed litigation today challenging a statewide ban on medical cannabis smoking.
“NORML ISU’s use of the cannabis leaf does not violate ISU’s trademark policies because the organization advocates for reform to marijuana laws, not the illegal use of marijuana,”
A three-judge panel of the US Court of Appeals for the 9th Circuit, covering nine western states, earlier this week ruled unanimously that the Department of Justice is barred by federal law from prosecuting medical marijuana businesses if those businesses are operating in compliance with state law.
The United States Drug Enforcement Administration has decided to reject a pair of administrative rescheduling petitions challenging the federal classification of cannabis as a Schedule I controlled substance with no accepted medical utility, according to advanced news reports published this evening by NPR, the New York Times, Reuters, and other news outlets.